University Medical Pharmaceuticals Corp.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From University Medical Pharmaceuticals Corp.
The National Advertising Review Board upholds a NAD ruling that the brand should discontinue claims comparing its Plantscription anti-aging serum to anti-wrinkle prescription products. NARB reversed several other NAD decisions on certain claims for the same product.
DERMAdoctor promotes its Photodynamic Therapy as a “liquid red light anti-aging lotion with broad spectrum SPF 30.” NAD says that the firm’s claims of equivalent or superior performance versus red-light devices are unsupported and should be discontinued.
NAD questioned DERMAdoctor claim in print ads that Photodynamic Therapy lotion users “get the same anti-aging red-light treatment without the hassle of cumbersome light gadgets, costly doctor visits or post-procedure downtime.”
ERSP clarifies requirements for quantified claims; food, veterinary medicine under same FDA office; FDA hosts forum on food safety regs; FDA OKs Reddy’s pediatric Allegra equivalent; Valeant finalizes Natur Produkt acquisition; FTC Chairman Jon Leibowitz to step down.
- OTC, Consumer
- Specialty Pharmaceuticals
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.